Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

Clinical trial NCT04906031 · UNKNOWN

Trial details

NCT number: NCT04906031
Sponsor: First Affiliated Hospital of Jinan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Acute Myeloid Leukemia Myeloid Malignancy Temperature-Sensitive p53 Mutation Sodium Stibogluconate P53 Mutation

Start date: 2020-06-01
Primary completion: 2023-02-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.